Injectable Prednisolone Administration and Dosage Guidelines
Injectable prednisolone should be administered based on the specific condition being treated, with dosages typically ranging from 4-60 mg daily for most conditions, administered intramuscularly or intravenously depending on the clinical scenario. 1
Dosage Recommendations
General Dosing Principles:
- Initial dosage of prednisolone may vary from 5-60 mg per day depending on the specific disease entity being treated 1
- Dosage requirements are variable and must be individualized based on:
- The disease being treated
- The severity of the condition
- The patient's response
Specific Dosing by Condition:
Inflammatory Conditions:
Pemphigus Vulgaris:
- Mild disease: 40-60 mg/day
- Severe disease: 60-100 mg/day
- If doses above 100 mg/day are required, consider pulsed intravenous corticosteroids 2
Polymyalgia Rheumatica:
- Oral prednisolone: 12.5-25 mg daily (initial dose)
- Alternative: Intramuscular methylprednisolone 120 mg every 3 weeks 3
Acute Gout:
- Oral prednisolone starting at 0.5 mg/kg/day for 5-10 days
- Intramuscular option: Single dose of 60 mg triamcinolone acetonide (equivalent to prednisolone) 4
Allergic/Respiratory Conditions:
Severe Urticaria/Angioedema:
- 50-100 mg prednisolone equivalent (liquid formulation preferred if dysphagia present) 5
Asthma Exacerbations:
- IV methylprednisolone (prednisolone equivalent: 4 mg methylprednisolone = 5 mg prednisolone) 6
Administration Routes:
Intramuscular (IM) Administration:
- Provides depot effect with slower absorption and longer duration
- Useful when oral administration is not possible or rapid effect is needed
- Less tissue atrophy compared to subcutaneous injection 7
Intravenous (IV) Administration:
- For severe conditions requiring rapid effect
- High-dose therapy should be administered over at least 30 minutes to reduce risk of cardiac arrhythmias 6
- Complete bioavailability (bioavailability fraction: 1.063 ± 0.154) 8
Monitoring and Adverse Effects
During Administration:
- Monitor for infusion reactions, particularly with IV administration
- For severe reactions (anaphylaxis):
- Stop administration immediately
- Maintain IV access
- Administer epinephrine 0.2-0.5 mg IM if needed 9
Long-term Monitoring:
- Monitor for hyperglycemia, especially following initial bolus
- Watch for hypertension and electrolyte disturbances
- Consider prophylaxis for:
- Pneumocystis pneumonia
- Gastric protection
- Osteoporosis prevention for prolonged courses 6
Tapering Recommendations
- After favorable response, determine maintenance dosage by decreasing initial dose in small decrements
- For long-term therapy, withdrawal should be gradual rather than abrupt 1
- For polymyalgia rheumatica: taper oral prednisolone by 1 mg/4 weeks (or 2.5 mg/10 weeks) until discontinuation 3
Important Considerations
- Injectable corticosteroids have been shown to be safe and effective for repeated use (every 3 months) for up to 2 years in joint conditions 7
- For critical illness-related corticosteroid insufficiency, hydrocortisone is preferred over prednisolone 10
- Long-term low-dose prednisone (<5 mg/day) may be effective for maintenance in rheumatoid arthritis 11
Corticosteroid Equivalent Doses
| Corticosteroid | Equivalent Dose (mg) | Relative Potency |
|---|---|---|
| Hydrocortisone | 20 | 1 |
| Prednisone | 5 | 4 |
| Prednisolone | 5 | 4 |
| Methylprednisolone | 4 | 5 |
| Triamcinolone | 4 | 5 |
| Dexamethasone | 0.75 | 25-30 |
Remember that the conversion ratio addresses dose equivalence but not duration of effect, and dosing frequency should be adjusted based on the half-life of the specific steroid.